We are live on ! Find out more
HCI

Harraden Circle Investments Portfolio holdings

AUM $499M
1-Year Est. Return 24.03%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+24.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$220M
AUM Growth
+$94.4M
Cap. Flow
+$103M
Cap. Flow %
46.58%
Top 10 Hldgs %
59.49%
Holding
142
New
37
Increased
26
Reduced
12
Closed
27
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEPO
1
Cantor Equity Partners I
CEPO
$272M
$19.3M 8.78%
+1,886,600
New +$19.1M
JACS
2
Jackson Acquisition Co II
JACS
$317M
$19.1M 8.7%
+1,901,322
New +$19.1M
SKGR
3
DELISTED
SK Growth Opportunities Corporation Class A Common Stock
SKGR
$14.9M 6.76%
1,220,000
+250,000
+26% +$2.93M
CLBR
4
DELISTED
Colombier Acquisition Corp II
CLBR
$13.1M 5.94%
1,227,550
+227,550
+23% +$2.46M
KDK
5
Kodiak AI
KDK
$776M
$12.8M 5.83%
+1,150,000
New +$12.7M
DRDB
6
Roman DBDR Acquisition Corp II
DRDB
$325M
$12.7M 5.78%
+1,267,364
New +$12.6M
CEP
7
DELISTED
Cantor Equity Partners
CEP
$11.1M 5.02%
1,029,000
+29,000
+3% +$301K
QSEAU
8
Quartzsea Acquisition Corp Units
QSEAU
$10.9M 4.94%
+1,075,789
New +$10.8M
BEAG
9
Bold Eagle Acquisition Corp
BEAG
$334M
$9.42M 4.28%
+928,000
New +$9.26M
SOC icon
10
Sable Offshore Corp
SOC
$836M
$7.64M 3.47%
300,962
+80,962
+37% +$2.07M
UYSCU
11
UY Scuti Acquisition Corp Units
UYSCU
$6.69M 3.04%
+665,000
New +$6.69M
NETD
12
DELISTED
Nabors Energy Transition Corp II
NETD
$6.67M 3.03%
+608,700
New +$6.64M
BOWN
13
DELISTED
Bowen Acquisition Corp
BOWN
$6.07M 2.76%
550,000
+154,796
+39% +$898K
BBOT
14
BridgeBio Oncology
BBOT
$660M
$5.95M 2.7%
526,535
+269,309
+105% +$2.89M
JVSA
15
DELISTED
JV SPAC Acquisition Corp
JVSA
$5.29M 2.4%
493,508
+343,508
+229% +$3.64M
OACC
16
Oaktree Acquisition Corp III Life Sciences
OACC
$264M
$5.14M 2.34%
+502,500
New +$5.04M
BAYA
17
DELISTED
Bayview Acquisition Corp
BAYA
$4.85M 2.2%
445,618
-98,532
-18% -$1.06M
BUJA
18
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
$4.57M 2.08%
393,398
-98,186
-20% -$1.11M
ALDF
19
Aldel Financial II Inc
ALDF
$321M
$4.34M 1.97%
429,051
+329,051
+329% +$3.3M
CCIX
20
DELISTED
Churchill Capital Corp IX
CCIX
$4.3M 1.95%
398,702
+356,896
+854% +$3.75M
USAR
21
USA Rare Earth Inc
USAR
$3.2B
$4.27M 1.94%
718,474
+18,474
+3% +$216K
KBSX
22
FST Corp
KBSX
$39.8M
$3.39M 1.54%
+1,642,573
New +$8.94M
TBMC
23
DELISTED
Trailblazer Merger Corp I
TBMC
$2.45M 1.11%
217,972
AIMBU
24
DELISTED
Aimfinity Investment Corp I Subunit
AIMBU
$1.94M 0.88%
160,001
-38,002
-19% -$460K
AFJK
25
Aimei Health Technology Co
AFJK
$37.7M
$1.65M 0.75%
150,000
+45,583
+44% +$494K

Similar funds

Harraden Circle Investments's Q1 2025 Portfolio in Review

As of Q1 2025, Harraden Circle Investments held 142 positions worth $220M, up 75% from $126M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Harraden Circle Investments deployed $103M of net new capital in Q1 2025, opening 37 new positions and adding to 26 existing holdings. Its largest new stake was Cantor Equity Partners I: 1,886,600 shares worth $19.3M.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 50% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Aspire Biopharma, an estimated $1.73M trimmed.

  • Harraden Circle Investments's largest Q1 2025 buy was Cantor Equity Partners I: 1,886,600 shares worth $19.3M.
  • Harraden Circle Investments added most to Churchill Capital Corp IX in Q1 2025, an estimated $3.75M increase.
  • Harraden Circle Investments's biggest Q1 2025 reduction was Aspire Biopharma, cutting an estimated $1.73M.
  • Harraden Circle Investments fully exited Jackson Acquisition Co II Units in Q1 2025, selling an estimated $15.1M.
  • Harraden Circle Investments's ten largest holdings make up 59% of its $220M portfolio in Q1 2025.
  • Harraden Circle Investments opened 37 new positions and closed 27 in Q1 2025.
  • Harraden Circle Investments's portfolio value rose 75% quarter-over-quarter to $220M.

Based on Harraden Circle Investments's 13F filing for Q1 2025, filed 15 May 2025.